Caffeine-inducible gene switches controlling experimental diabetes
Control of transgene expression should ideally be easy and with minimal side effects. Here the authors present a synthetic biology-based approach in which the caffeine in coffee regulates a genetic circuit controlling glucagon-like peptide 1 expression in diabetic mice.
Guardado en:
Autores principales: | Daniel Bojar, Leo Scheller, Ghislaine Charpin-El Hamri, Mingqi Xie, Martin Fussenegger |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/78897e8e6b274e48b9f08daab11ccd6a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Design of modular autoproteolytic gene switches responsive to anti-coronavirus drug candidates
por: Nik Franko, et al.
Publicado: (2021) -
Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson’s disease treatment
por: Ryosuke Kojima, et al.
Publicado: (2018) -
Experimental study of the effect of Caffeine on Pentazocine analgesia
por: A Arzi, et al.
Publicado: (1999) -
Rewiring of endogenous signaling pathways to genomic targets for therapeutic cell reprogramming
por: Krzysztof Krawczyk, et al.
Publicado: (2020) -
One Week of Low or Moderate Doses of Caffeinated Coffee Consumption Does Not Induce Tolerance to The Accute Effects of Caffeine on Sprint Performance
por: Raci Karayigit, et al.
Publicado: (2021)